Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 609-765-0 | CAS number: 39987-85-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- other information
- Study period:
- Feb to Mar 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- - modified maximization test: an epidermal induction on the scarified skin is performed instead of intracutaneous induction
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: liquid parrafin
- Concentration / amount:
- intradermal induction: see "Any other information on materials and methods"
topical induction (days 1, 2 and 3): 25 %
topical challenge (days 21 and 28): 25 % - Route:
- epicutaneous, occlusive
- Vehicle:
- other: liquid parrafin
- Concentration / amount:
- intradermal induction: see "Any other information on materials and methods"
topical induction (days 1, 2 and 3): 25 %
topical challenge (days 21 and 28): 25 % - No. of animals per dose:
- control group: 10 (5/sex)
test substance group: 10 (5/sex)
pre-test (local tolerance test, rechallenge control group): 6 (3/sex) - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- challenge 25 %
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Clinical observations:
- very slight to slight reddenings
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: challenge 25 %. No with. + reactions: 1.0. Total no. in groups: 9.0. Clinical observations: very slight to slight reddenings.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- challenge 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: challenge 25 %. No with. + reactions: 0.0. Total no. in groups: 9.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- challenge 25 %
- No. with + reactions:
- 2
- Total no. in group:
- 9
- Clinical observations:
- very slight to slight reddenings
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: challenge 25 %. No with. + reactions: 2.0. Total no. in groups: 9.0. Clinical observations: very slight to slight reddenings.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- challenge 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: challenge 25 %. No with. + reactions: 0.0. Total no. in groups: 9.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- very slight to slight reddenings
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: very slight to slight reddenings.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 3
- Total no. in group:
- 6
- Clinical observations:
- very slight to slight reddenings
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 3.0. Total no. in groups: 6.0. Clinical observations: very slight to slight reddenings.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 6
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: none.
- Executive summary:
In a modified guinea pig maximization test (GPMT) according to OECD TG 406 no skin sensitizing potential of the test substance could be observed based on the results after the first challenge and the rechallenge with 25 % ZK 9340.
Reference
One female animal of the test group was found dead on day 2. The animal had possibly died from stress (due to the bandage) during the first induction.
After the first challenge and the rechallenge 1 or 2 of a total of 9 animals showed very slight to slight reddenings on the treated area only 24 hours after the end of challenge. Very slight to slight reddenings each occurred in 3 control animals (first challenge 3/10, rechallenge 3/6).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a guinea pig maximization test (GPMT) according to OECD TG 406 the test substance ZK 9340 (M-DOC) revealed an ambiguous result after an intradermal induction concentration of 1.25 % ZK 9340 followed by a topical induction concentration of 25 % (Schöbel, 1996a). Based on this study it is not possible to come to any clear conclusion as to whether ZK 9340 possesses a sensitizing effect in the guinea-pig.
In a modified guinea pig maximization test (GPMT) according to OECD TG 406 no skin sensitizing potential of the test substance ZK 9340 (M-DOC) could be observed based on the results after the first challenge and the rechallenge with 25 % ZK 9340 (Schöbel, 1996b). In this test the animals were topically induced with a concentration of 25 % test substance.
Therefore, regarding the results of the previous study (Schöbel, 1996a) and the present study (Schöbel, 1996b) ZK 9340 was proved to have no sensitizing effect in the guinea-pig using the maximization test as weil as the modified maximization test with higher concentrations for induction.
Under consideration of the molecular structure similarity of M-DOC and M-DOCA the results on skin sensitisation of M-DOC has been accepted for M-DOCA (read-across approach).
Migrated from Short description of key information:
Guinea pig maximation test: not sensitising [Schöbel 1996b]
Justification for selection of skin sensitisation endpoint:
First GPMT (Schöbel, 1996a) revealed an ambiguous result since intradermal induction concentration of 1.25 % was to low.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the study results a classification according to Directive 67/548/EEC or Regulation (EC) No. 1272/2008 (CLP) is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.